Palliative Vitamin C Application in Patients with Radiotherapy-Resistant Bone Metastases: A Retrospective Study

REFERENCES

• McLaughlin JK, Gridley G, Block G, Winn DM, Preston-Martin S, et al.: Dietary factors in oral and pharyngeal cancer. JNCI 80, 1237–1243, 1988.
   PubMed Web of Science ®Google Scholar
• Graham S, Mettlin C, Marshall J, Priore R, Rzepka T, et al.: Dietary factors in the epidemiology of cancer of the larynx. Am I Epidemiol 13, 675–680, 1981.
   Web of Science ®Google Scholar
• Brown LM, Blot WI, Schuman SH, Smith VM, Ershow AG, et al.: Environmental factors and high risk of esophageal cancer among men in coastal South Caroli. JNCI 80, 1620–1625, 1988.
   PubMed Web of Science ®Google Scholar
• Fontham ETH, Pickle LW, Haenszel W, Correa, P, Lin, Y, et al.: Dietary vitamins A and C and lung cancer risk in Louisiana. Cancer 62, 2267–2273, 1988.
   PubMed Web of Science ®Google Scholar
• Falk RT, Pickle LW, Fontham ET, Correa P, Fraumeni JF, et al.: Lifestyle risk factors for pancreatic cancer in Louisiana: a case-control study. Am I Epidemiol 128, 324–336, 1988.
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Negri E, Decarli A, D'Avanzo B, and Franceschi S: A case-control study ofdiet and gastric cancer in northern Italy. Int I Cancer 40, 484–489, 1987.
   PubMed Web of Science ®Google Scholar
• Verreault R, Chu I, Mandelson M, and Shy K: A case-control study of diet and invasive cervical cancer. Int I Cancer 43, 1050–1054, 1989.
   PubMed Web of Science ®Google Scholar
• Kune GA, and Kune S: The nutritional causes ofcolorectal cancer: an introduction to the Melbourne Study. Nutr Cancer 9, 1–4, 1987.
   PubMedGoogle Scholar
• Slattery ML, Schuman KL, West DW, et al.: Nutrient intake and ovarian cancer. Am I Epidemiol 130, 497–502, 1989.
   PubMed Web of Science ®Google Scholar
• La Veechia C, Decarli A, Fasoli M, and Gentile A: Nutrition and diet in the etiology ofendometrial cancer. Cancer 57, l248–1253, 1986.
   Web of Science ®Google Scholar
• Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, et al.: Dietary factors and risk of breast cancer combined analysis of 12 case-control studies. JNCI 82, 1–9, 1990.
   Web of Science ®Google Scholar
• Yeom CH, Lee G, Park JH, Yu J, and Park S: High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis. J of Translational Med 7(70), 2009.
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, et al.: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci 105, 11105–11109, 2008.
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, et al.: Intravenously administered vitamin C as cancer therapy: three cases. CMAJ 174, 937–942, 2006.
   PubMed Web of Science ®Google Scholar
• Cha J, Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, et al.: Ascorbate depletion increases growth and metastasis of melanoma cells in vitamin C deficient mice. Exp Oncol 33, 226–230, 2011.
   PubMedGoogle Scholar
• Mikirova NA, Ichim TE, and Riordan NH. Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med 6(50), 2008. doi:10.1186/1479-5876-6-50
   PubMed Web of Science ®Google Scholar
• Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, et al.: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84, 1470–1478, 1989.
   PubMed Web of Science ®Google Scholar
• Plate KH, Breier G, Weich HA, and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845–848, 1992.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Olson TA, Bautch VL, and Mohanraj D: Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res 56, 1324–1330, 1996.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, et al.: Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 76, 1221–1227, 1997.
   PubMed Web of Science ®Google Scholar
• Staack A, Badendieck S, Schnorr D, et al.: Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder. BMC Urol 6(19), 2006. doi:10.1186/1471-2490-6-19
   PubMedGoogle Scholar
• Cameron E, and Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 9, 285–315, 1974.
   PubMed Web of Science ®Google Scholar
• Cameron E, and Pauling L: Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci 73, 3685–3689, 1976.
   PubMed Web of Science ®Google Scholar
• Cameron E, and Pauling L: Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases. Oncology 27, 181–192, 1973.
   PubMed Web of Science ®Google Scholar
• Cameron E, and Campbell A: Innovation vs. quality control: an ‘unpublishable’ clinical trial of supplemental ascorbate in incurable cancer. Med Hypotheses 36, 185–189, 1991.
   PubMed Web of Science ®Google Scholar
• Cameron E, Campbell A, and Jack T: The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact 11, 387–393, 1975.
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, et al.: Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 5(7), e11414, 2010.
   PubMed Web of Science ®Google Scholar
• DeWys WD: How to evaluate a new treatment for cancer. Your Patient and Cancer 2(5), 31–36, 1982.
   Google Scholar
• Roodman GD: Mechanisms of bone metastasis. N Engl J Med 350, 1655–1664, 2004.
   PubMed Web of Science ®Google Scholar
• Morrison LJ, and Morrison RS: Palliative care and pain management. Med Clin North Am 90, 983–1004, 2006.
   PubMed Web of Science ®Google Scholar
• Buccheri G, Ferrigno D, and Tamburini M: Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single ınstitution. European J of Cancer 32, 1135–1141, 1996.
   Web of Science ®Google Scholar
• Bijur PE, Silver W, and Gallagher EJ: Reliability of the Visual Analog Scale for measurement of acute pain. Academic Emergency Med 8, 1153–1157, 2001.
   PubMed Web of Science ®Google Scholar
• Kiziltan HS, Bayir AG, Demirtas M, Meral I, Taspinar O, et al.: Ascorbic-acid treatment for progressive bone metastases after radiotherapy: a pilot study. ATHM 20, 16–20, 2014.
   Google Scholar
• Mayland CR, Bennett MI, and Allan K: Vitamin C deficiency in cancer patients. Palliat Med 19, 17–20, 2005.
   PubMed Web of Science ®Google Scholar
• Barness LA: Safety considerations with high ascorbic acid dosage. Ann N Y Acad Sci 258, 523–528, 1975.
   PubMed Web of Science ®Google Scholar
• Rycaj K, Tang DG. Cancer stem cells and radioresistance. Int J Radiat Biol 90(8), 1–7, 2014. doi:10.3109/09553002.2014.892227
   PubMed Web of Science ®Google Scholar
• Chargari C, Clemenson C, Martins I, Perfettini JL, Deutsch E, et al.: Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Drug Resist Update 16(1–2), 10–21, 2013.
   PubMed Web of Science ®Google Scholar
• University of Michigan Health System: Bone Metatasis Retrieved from http://www.cancer.med.umich.edu/cancertreat/tissue_bone/bone_metastasis.shtml
   Google Scholar